CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B.

MLA

Tang, Qiyu, et al. “CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human IPSCs for Gene Therapy of Hemophilia B.” International Journal of Molecular Sciences, vol. 24, no. 10, May 2023, p. 9013. EBSCOhost, https://doi.org/10.3390/ijms24109013.

APA

Tang, Q., Hu, Z., Zhao, J., Zhou, T., Tang, S., Wang, P., Xiao, R., Chen, Y., Wu, L., Zhou, M., & Liang, D. (2023). CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B. International Journal of Molecular Sciences, 24(10), 9013. https://doi.org/10.3390/ijms24109013

Chicago

Tang, Qiyu, Zhiqing Hu, Junya Zhao, Tao Zhou, Shuqing Tang, Peiyun Wang, Rou Xiao, et al. 2023. “CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human IPSCs for Gene Therapy of Hemophilia B.” International Journal of Molecular Sciences 24 (10): 9013. doi:10.3390/ijms24109013.